Toric IOL enhances refractive outcomes

Rayner, the world's first IOL manufacturer, unveiled a dynamic new brand identity at ESCRS and held a seminar today to highlight the success doctors are having with its range of toric IOLs. Headlined A Roadmap to Success the seminar featured presentations from seven European doctors relating their experiences of using Rayner's toric IOLs.

According to Rod Santos, marketing manager, Rayner has a broad offering in toric, with three lenses; T-flex, M-flex and Sulcoflex. Subjects covered in the seminar included options for the correction of astigmatism and the benefit of multifocal toric IOLs.

For Santos, the highlight of the programme was a presentation by Michael Amon dealing with enhancing refractive outcomes with Rayner's Sulcoflex toric IOL. Amon is the innovator behind the Sulcoflex lense and the seminar marks an important point in the three-year life of the Sulcoflex range.

“Michael Amon had a good idea and brought it to Rayner. Development began three years ago, we took it to market two years ago and, in our ESCRS seminar, we heard very positive report on results and outcomes,” said Santos.

Sulcoflex is a pseudophakic supplementary IOL, manufactured from Rayner's proprietary hydrophilic acrylic co-polymer Rayacryl. It piggy-backs where the patient has already received a primary IOL and has been designed to minimise the potential for contact between the two implants. This reduces the likelihood of induced refractive error and optical aberrations due to optic surface distortion.

OTEurope will be reporting on the doctors' findings in a later edition.